Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and Heteroresistance.

Improving the Quantification of Colorimetric Signals in Paper-Based Immunosensors with an Open-Source Reader

Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic activity.

Micro- and nanosensors for detecting blood pathogens and biomarkers at different points of sepsis care.

Plasma-induced nanoparticle aggregation for stratifying COVID-19 patients according to disease severity.

Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units.

Reinforcement of the Standard Therapy with Two Infusions of Convalescent Plasma for Patients with COVID-19: A Randomized Clinical Trial.

Polymer Components for Paper‐Based Analytical Devices

To update or not to update the ESCMID guidelines for the diagnosis and treatment of biofilm infections – That is the question! The opinion of the ESGB board.

Mutation Analysis in Regulator DNA-Binding Regions for Antimicrobial Efflux Pumps in 17,000 Pseudomonas aeruginosa Genomes.